US1598641074
US1598641074
Charles River Laboratories Inte
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.015.382.000 | 4.049.989.000 | 0.9% |
| Cost of Revenue | 2.692.107.000 | 2.718.168.000 | 1.0% |
| Gross Profit | 1.323.275.000 | 1.331.821.000 | 0.6% |
| 922.139.000 | 889.474.000 | 3.7% | |
| Operating Income | 401.136.000 | 442.347.000 | 9.3% |
| Pretax Income | -99.503.000 | 93.114.000 | 206.9% |
| Net Income Common Stockholders | -144.338.000 | 10.297.000 | 1501.7% |
| -- | -- | -- | |
| -- | -- | -- |